Cancer is the first cause of death in developed countries and the second in developing
countries. Concerning the most frequent worldwide-diagnosed cancer, primary liver cancer …

Background: Liver cancer is the fifth most commonly diagnosed cancer and the second
leading cause of cancer-related deaths worldwide. Among the liver cancers, hepatocellular …

Diethylnitrosamine (DEN) is a well‐known hepatocarcinogen, and its oral administration
causes severe liver damage including cancer. DEN induces the pathogenesis of the liver …

Hepatocellular carcinoma (HCC) has been identified as one of the most deadly
malignancies with limited therapeutic efficacy worldwide. However, understanding the …

Objective Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer usually
arising on a background of chronic liver injury involving inflammatory and hepatic …

Purpose Hepatocellular carcinoma (HCC) cases are closely associated with chronic
inflammation and fibrosis which is known as hepatic inflammation-fibrosis-cancer (IFC) axis …

Hepatocellular carcinoma (HCC) is a leading cause of cancer related deaths worldwide. It
was suggested that albendazole (ABZ) is a powerful inhibitor of several carcinoma types …

The catalytic activity of cerium oxide nanoparticles (CeO2NPs) is responsible for its
application as an antitumor agent. This activity may be due to its ability to switch between III …

Background The incidence of hepatocellular carcinoma with nonalcoholic steatohepatitis is
increasing, and its clinicopathological features are well established. Several animal models …

Medicinal mushrooms are increasingly being recognized as an important therapeutic
modality in complementary oncology. Until now, more than 800 mushroom species have …